CSF thiamine values were very low (mean (SD) 14 6 (4-2) ng/ml) despite normal blood thiamine levels.
Discussion
The observed discrepancy between normal blood thiamine values and low CSF thiamine levels agrees with our previous findings in epileptic patients with cerebellar atrophies compared with those with normal CT scans9 as well as with Poloni and Patrini's data4 on a small number of ataxic patients. The normal CSF values in the present study are higher than those in untreated epileptic patients reported in a previous investigation. This difference may be due to cerebellar atrophy being encountered in about 15% of cases of untreated epilepsy811; however, atrophy is more common and more severe in chronically treated epileptics. In our earlier study of 35 untreated epileptics, seven displayed mild or moderate cerebellar atrophy, and this could account for the difference because untreated epileptics should not be considered as normal controls; their CSF thiamine values were considered to be similar to control values only for the other epileptic groups. The low CSF thiamine values in our patients could not be explained by a deficient diet because all patients and controls had normal dietary assessments. The cerebellum, medulla, and pons in rats have the highest thiamine turnover rate in the CNS,`2 the most obvious thiamine depletion occurring after deprivation,'3 and these are the first regions to develop lesions.'4 15 The olivary nucleus, pontine nuclei, decussation of the superior cerebellar peduncles, and dentate nucleus are highly sensitive to thiamine deficiency in mon-
keys.16
Thiamine is transported across the bloodbrain barrier by two separate mechanisms: one saturable (probably carrier-mediated), which accounts for 91% (cerebral cortex) to 96% (cerebellum) of the total transport of labelled thiamine at physiological plasma levels, and the other non-saturable (4-9).16 17 If anything interferes with the carrier-mediated component of thiamine transport across the bloodbrain barrier, the supply of the vitamin in the brain will become inadequate. 718 We propose two mechanisms to explain the low CSF thiamine levels in our patients in the absence of a blood thiamine deficiency. A primary mechanism located in the cerebellum itself-that is, cerebellar atrophy-may induce a lowering of brain and CSF thiamine because the cerebellum has the highest content and turnover of the vitamin among all other nervous structures'2; the severe cerebellar atrophy encountered in OPCA patients could explain their low CSF thiamine levels whereas in Friedreich's ataxia patients in whom cerebellar atrophy is less pronounced, CSF thiamine levels are relatively higher; the low CSF thiamine values recorded in patients with Charlevoix-Saguenay spastic recessive ataxia may be attributed to their massive vermal atrophy.'0 A secondary mechanism-that is, cerebellar and brainstem atrophy-may decrease the vascular surface, diminishing saturable transfer of the vitamin across the blood-brain barrier and reducing CSF thiamine levels. 
